Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system

Bibliographic Details
Published in:	HeartRhythm Case Reports
Main Authors:	Konstantinos Kossidas, MD, FHRS, Richard Kalman, RN, William P. Follis, RN, Joshua M. Cooper, MD
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Subjects:	Pacemaker Subcutaneous implantable cardioverter-defibrillator (S-ICD) Implantable cardioverter-defibrillator (ICD) Epicardial pacemaker lead Unipolar pacing Cross talk
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027117301525

Similar Items

Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)

Subcutaneous defibrillator use with unipolar pacemakers: Cautiously possible
by: Matanyahu Rubinstein, et al.
Published: (2023-07-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)

Variation in Lead Impedance according to Pacemaker Analyzing Systems
by: Hiroshi Ichiyanagi, et al.
Published: (2010-01-01)

Cardiac implantable electronic devices in Bulgaria: results from the electronic registry BG-Pace for 2022
by: V. Traykov, et al.
Published: (2023-12-01)

How does the ICD recognize the type of arrhythmia? Tachyarrhythmia discrimination in modern transvenous cardioverter defibrillators
by: Flóra Diána Gausz, et al.
Published: (2025-08-01)

Bioelectrical impedance analysis of body composition: influence of a newly implanted cardiac device
by: Pinto Luiz Wellington, et al.
Published: (2017-07-01)

Postoperative intravenous patient‐controlled analgesia improves pain management after subcutaneous implantable defibrillator implantation
by: Kenta Tsutsui, et al.
Published: (2024-04-01)

Outcomes of permanent pacemakers and implantable cardioverter-defibrillators in an adult congenital heart disease population
by: Jason Chami, et al.
Published: (2024-03-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)

Predictors of pacing-dependency in patients with cardiovascular implantable electronic devices
by: Wolfram Grimm, et al.
Published: (2021-05-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)

Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center Two-Year Survey
by: John Fanourgiakis, et al.
Published: (2016-01-01)

Cardiac implantable electronic devices in Bulgaria: results from the electronic registry BG-Pace for the period 2019-2021
by: Vassil Traykov, et al.
Published: (2021-10-01)

Radiotherapy for patients with cardiovascular implantable electronic device-a single institutional experience
by: Bhargavi Ilangovan, et al.
Published: (2022-01-01)

A case of pioneering subcutaneous implantable cardioverter defibrillator intervention in Timothy syndrome
by: Zixi Zhang, et al.
Published: (2024-11-01)

Lead management in setting of limited venous accesses: A case report and review of literature
by: Mohsin Khan, MD, et al.
Published: (2021-08-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

A case report of a combined implantation technique of a cardioverter-defibrillator in an infant with long QT syndrome type 8 (Timothy's syndrome)
by: Sergei Viktorovich Nemtsov, et al.
Published: (2024-11-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
by: Szymon Budrejko, et al.
Published: (2023-12-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)

Double‐device therapy in a patient with long QT syndrome
by: Shohei Kataoka, et al.
Published: (2024-06-01)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
by: Amit Noheria, MBBS, SM, et al.
Published: (2014-11-01)

Routine DFT testing in patients undergoing ICD implantation does not improve mortality: A systematic review and meta‐analysis
by: Munish Kannabhiran, et al.
Published: (2018-12-01)

“I don’t know exactly what you’re referring to”: the challenge of values elicitation in decision making for implantable cardioverter-defibrillators
by: Carroll SL, et al.
Published: (2018-09-01)

Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; A prospective study
by: Safi Morteza, et al.
Published: (2017-09-01)

A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland
by: Maciej Kempa, et al.
Published: (2023-04-01)

Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Anti-arrhythmic device therapy has limits in improving the prognosis of patients with cardiac amyloidosis
by: Toshiya Kojima, et al.
Published: (2012-08-01)